Upgrade to SI Premium - Free Trial

Tempest Therapeutics (TPST)

1.27 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (3/19/26 *Est.)

Latest Headlines

Form 3 Tempest Therapeutics, For: Jun 04 Filed by: Richey William Drake June 8, 2026 9:01 PM - SEC Filing Form 4 Tempest Therapeutics, For: Jun 04 Filed by: Richey William Drake June 8, 2026 6:18 PM - SEC Filing Form DEF 14A Tempest Therapeutics, For: Jun 18 June 8, 2026 4:07 PM - SEC Filing Form 8-K Tempest Therapeutics, For: May 29 June 4, 2026 5:00 PM - SEC Filing Tempest Therapeutics adds two independent directors to board June 4, 2026 4:37 PM - StreetInsider Tempest Therapeutics Appoints Drake Richey and John Yee, MD, MPH to Board of Directors June 4, 2026 4:37 PM - Globe NewsWire Form 8-K Tempest Therapeutics, For: May 28 June 2, 2026 6:05 AM - SEC Filing Form PRE 14A Tempest Therapeutics, For: Jun 18 May 29, 2026 5:06 PM - SEC Filing Form 8-K Tempest Therapeutics, For: May 23 May 29, 2026 5:01 PM - SEC Filing Tempest Therapeutics raises $2 million through warrant exercise May 29, 2026 8:02 AM - StreetInsider Tempest Therapeutics Announces Warrant Exercise for Approximately $2 Million in Gross Proceeds May 29, 2026 8:00 AM - StreetInsider Form 8-K Tempest Therapeutics, For: May 19 May 22, 2026 5:28 PM - SEC Filing Form 8-K Tempest Therapeutics, For: May 22 May 22, 2026 5:06 PM - SEC Filing Form 10-Q Tempest Therapeutics, For: Mar 31 May 14, 2026 5:04 PM - SEC Filing Form 8-K Tempest Therapeutics, For: May 14 May 14, 2026 4:29 PM - SEC Filing Tempest Reports First Quarter 2026 Financial Results and Provides Business Update May 14, 2026 4:15 PM - StreetInsider Form 8-K Tempest Therapeutics, For: May 06 May 6, 2026 7:46 AM - SEC Filing Tempest Presents Clinical Update at ISCT 2026 Annual Meeting May 6, 2026 7:00 AM - Globe NewsWire Tempest to Advance Dual-Targeting CAR-T Platform with Clinical Update at ISCT 2026 Annual Meeting April 29, 2026 8:00 AM - Globe NewsWire Tempest delivers manufacturing component for CAR-T therapy development April 22, 2026 8:04 AM - StreetInsider Tempest Announces Key Manufacturing Milestone for TPST-2003 Dual-Targeting CD19/BCMA CAR-T April 22, 2026 8:00 AM - StreetInsider Tempest Therapeutics names Andrew Fang as head of business development April 14, 2026 8:04 AM - StreetInsider Tempest Appoints Andrew Fang, Ph.D., as Head of Business Development to Advance Strategic Partnerships and Global Licensing Efforts April 14, 2026 8:01 AM - Globe NewsWire Form 424B3 Tempest Therapeutics, April 10, 2026 9:26 AM - SEC Filing Form 424B3 Tempest Therapeutics, April 10, 2026 9:25 AM - SEC Filing Form EFFECT Tempest Therapeutics, April 10, 2026 6:03 AM - SEC Filing Form EFFECT Tempest Therapeutics, April 6, 2026 6:01 AM - SEC Filing Form D Tempest Therapeutics, April 3, 2026 2:28 PM - SEC Filing Form 4 Tempest Therapeutics, For: Mar 31 Filed by: Trojanowski Justin April 2, 2026 5:01 PM - SEC Filing Form 4 Tempest Therapeutics, For: Mar 31 Filed by: Maestas Nicholas April 2, 2026 5:01 PM - SEC Filing Form SCHEDULE 13D/A Tempest Therapeutics, Filed by: Versant Venture Capital VI, L.P. April 2, 2026 4:31 PM - SEC Filing Tempest Therapeutics (TPST) files for 2.78M share offering by selling stockholders April 2, 2026 6:09 AM - StreetInsider Form S-3 Tempest Therapeutics, April 2, 2026 6:06 AM - SEC Filing Form S-8 POS Tempest Therapeutics, March 31, 2026 6:20 AM - SEC Filing Form S-3 Tempest Therapeutics, March 30, 2026 5:59 PM - SEC Filing Form S-8 Tempest Therapeutics, March 30, 2026 5:57 PM - SEC Filing Tempest Reports Year End 2025 Financial Results and Provides Business Update March 30, 2026 9:00 AM - StreetInsider Form 10-K Tempest Therapeutics, For: Dec 31 March 30, 2026 8:36 AM - SEC Filing Form 8-K Tempest Therapeutics, For: Mar 30 March 30, 2026 8:28 AM - SEC Filing Form SCHEDULE 13D/A Tempest Therapeutics, Filed by: Angel Matthew March 25, 2026 5:34 PM - SEC Filing Form 4 Tempest Therapeutics, For: Mar 24 Filed by: Angel Matthew March 25, 2026 5:32 PM - SEC Filing Form 8-K Tempest Therapeutics, For: Mar 20 March 23, 2026 8:17 AM - SEC Filing Tempest Therapeutics raises $2 million in private placement March 23, 2026 8:00 AM - StreetInsider Tempest Therapeutics Announces Up To $6 Million Private Placement March 23, 2026 8:00 AM - StreetInsider Tempest Announces Partnership for TPST-2003 in Preparation for Planned U.S. Registrational Study in 2026 March 11, 2026 8:00 AM - StreetInsider Full Article List